COVID-19: Drug Development and Kidney Related Problems
Abstract
Mohammad Rudiansyah, Hendra Wana Nurâamin, Dwi Aris Agung Nugrahaningsih, Ria Bandiara, Rully Marsis Amirullah Roesli.
Coronavirus Disease-2019 (COVID-19) is an extremely contagious disease affecting almost every country in the world. This disease makes some problems in the health system, society, politics, and economy. Several reports showed that mortality in COVID-19 patients was related to abnormal kidney function. This condition should be considered to prevent death. Some investigational drugs are on the way in the preclinical and clinical trials. Some of them no have a study for safety in the kidney especially in chronic kidney disease patients including those who undergo hemodialysis. Some give a satisfying effect. Understanding COVID-19, kidney diseases, and drugs will help us to get the most potent treatment.
| How to Cite this Article |
| Pubmed Style Rudiansyah M, Nur'amin HW, Nugrahaningsih DAA, Bandiara R, Roesli RMA. COVID-19: Drug Development and Kidney Related Problems. SRP. 2020; 11(7): 106-112. doi:10.31838/srp.2020.7.17 Web Style Rudiansyah M, Nur'amin HW, Nugrahaningsih DAA, Bandiara R, Roesli RMA. COVID-19: Drug Development and Kidney Related Problems. http://www.sysrevpharm.org/?mno=120278 [Access: March 28, 2021]. doi:10.31838/srp.2020.7.17 AMA (American Medical Association) Style Rudiansyah M, Nur'amin HW, Nugrahaningsih DAA, Bandiara R, Roesli RMA. COVID-19: Drug Development and Kidney Related Problems. SRP. 2020; 11(7): 106-112. doi:10.31838/srp.2020.7.17 Vancouver/ICMJE Style Rudiansyah M, Nur'amin HW, Nugrahaningsih DAA, Bandiara R, Roesli RMA. COVID-19: Drug Development and Kidney Related Problems. SRP. (2020), [cited March 28, 2021]; 11(7): 106-112. doi:10.31838/srp.2020.7.17 Harvard Style Rudiansyah, M., Nur'amin, . H. W., Nugrahaningsih, . D. A. A., Bandiara, . R. & Roesli, . R. M. A. (2020) COVID-19: Drug Development and Kidney Related Problems. SRP, 11 (7), 106-112. doi:10.31838/srp.2020.7.17 Turabian Style Rudiansyah, Mohammad, Hendra Wana Nur'amin, Dwi Aris Agung Nugrahaningsih, Ria Bandiara, and Rully Marsis Amirullah Roesli. 2020. COVID-19: Drug Development and Kidney Related Problems. Systematic Reviews in Pharmacy, 11 (7), 106-112. doi:10.31838/srp.2020.7.17 Chicago Style Rudiansyah, Mohammad, Hendra Wana Nur'amin, Dwi Aris Agung Nugrahaningsih, Ria Bandiara, and Rully Marsis Amirullah Roesli. "COVID-19: Drug Development and Kidney Related Problems." Systematic Reviews in Pharmacy 11 (2020), 106-112. doi:10.31838/srp.2020.7.17 MLA (The Modern Language Association) Style Rudiansyah, Mohammad, Hendra Wana Nur'amin, Dwi Aris Agung Nugrahaningsih, Ria Bandiara, and Rully Marsis Amirullah Roesli. "COVID-19: Drug Development and Kidney Related Problems." Systematic Reviews in Pharmacy 11.7 (2020), 106-112. Print. doi:10.31838/srp.2020.7.17 APA (American Psychological Association) Style Rudiansyah, M., Nur'amin, . H. W., Nugrahaningsih, . D. A. A., Bandiara, . R. & Roesli, . R. M. A. (2020) COVID-19: Drug Development and Kidney Related Problems. Systematic Reviews in Pharmacy, 11 (7), 106-112. doi:10.31838/srp.2020.7.17 |
Abstract
PDF
How to cite this article
Related Records